Bulk tumor tissue RNA-seq analysis revealed that BAY-I treatment led to significantly increased IFNγ, T-cell receptor and cytokine-cytokine receptor signaling pathways (Fig. 2D). This evidence concerns the gene IFNG and neoplasm.